Skip to content

Eli Lilly LLY Price / earnings

Price / earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
Pfizer logo
PfizerPFE
14.7×
Amgen logo
AmgenAMGN
24.3×-3.9×
Cardinal Health logo
Cardinal HealthCAH
32×+10.6×
Biogen logo
BiogenBIIB
18.9×+5.4×
McKesson logo
McKessonMCK
22.3×-3.3×

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$991.62B+10.8%
Enterprise value$1.03T+10.6%
P/S13.7×-4.5×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Eli Lilly’s reported figures.

Based on the most recent quarter.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's price / earnings?
Eli Lilly (LLY) reported price / earnings of 32.5× in Q1 2026.
How has Eli Lilly's price / earnings changed year-over-year?
Eli Lilly's price / earnings decreased by 51.3% year-over-year, from 66.8× to 32.5×.
What is the long-term trend for Eli Lilly's price / earnings?
Over 4 years (2021 to 2025), Eli Lilly's price / earnings has grown at a 7.6% compound annual growth rate (CAGR), from 149.8× to 201.1×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.